Boost Clinical Lab Efficiency with the ThunderBolt EIA+CLIA Automation Platform

16 Aug 2012
Gold Standard Diagnostics (GSD) have announced the addition of fully-automated Chemiluminescence Immunoassay (CLIA) processing capability to the powerful ThunderBolt® Automation Platform. With the ability to simultaneously automate CLIA alongside EIA, laboratories of any size can now achieve even more dramatic increases in throughput, flexibility and cost savings.

Through a host of patent-pending features, the ThunderBolt® delivers exceptional power and flexibility in a small size. The dual function analyzer provides complete, walk-away automation of 192 patient samples in only a 2’ by 2’ space. Completely open architecture allows any EIA or CLIA protocol to be programmed, and up to eight different protocols to run in a single batch. Intuitive and robust software further enriches the ThunderBolt®, making it the total laboratory automation solution.

Gold Standard Diagnostics also boasts a suite of over 200 “ThunderBolt-Ready” assays from more than 20 different manufacturers. Each validated protocol in the large library deploys seamlessly on the ThunderBolt® to realize maximum laboratory benefit as quickly as possible. GSD also supports the entire solution of reagents and instrumentation to guarantee smooth operation and maximum uptime.

Request Info

Company website

Gold Standard Diagnostics
profile photo

Sonia Nicholas
Clinical Diagnostics Editor